Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases

Anticancer Res. 2000 Jan-Feb;20(1A):311-6.

Abstract

Background: Immunohistochemical expression of the transcription factor Pax-8 in human thyroid diseases has never been investigated. The relationship between Pax-8, bcl-2 and p53 in thyroid neoplasms is also matter of interest.

Materials and methods: Seventy-three thyroid tissue samples were evaluated for the expression of Pax-8, p53 and bcl-2 using the immunoperoxidase technique. The series included 11 follicular adenomas, 11 goitres, 23 papillary carcinomas, 16 follicular carcinomas, 6 undifferentiated carcinomas and 6 medullary carcinomas.

Results: The percentage of Pax-8 positive cells ranged from 14.9 to 27.1% and 10.1 to 39% in goitres and follicular adenomas, respectively. Among differentiated carcinomas, follicular histotype showed a Pax-8 immunoreactivity ranging from 0 to 26.5% of the neoplastic cells whereas in papillary carcinomas the percentage of positive cells ranged from 0 to 16.8%. None out of the six undifferentiated carcinomas showed Pax-8 immunoreactivity. The same negative pattern was noticed in medullary carcinomas. A statistically significant difference in Pax-8 expression was observed between non-malignant and malignant diseases (p < 0.0001). A different reactivity for Pax-8 was also noticed between differentiated carcinomas and undifferentiated carcinomas (p = 0.07). None of the benign tissues stained for p53 whereas among malignant specimens different percentages of p53 expression were observed with all undifferentiated carcinomas expressing the highest positivity (range 24.1-88.6%). Finally, when a combined analysis of bcl-2 and Pax-8 reactivity was carried out, some carcinomas proved to be Pax-8 negative and bcl-2 positive whereas others showed a similar immunoreactive pattern for both Pax-8 and bcl-2.

Conclusions: Pax-8 is mainly expressed in benign rather than in malignant thyroid diseases and, among neoplasms, differentiated carcinomas express Pax-8 more frequently than undifferentiated carcinomas. An inverse pattern was observed for p53. Bcl-2 seems to be partially related to Pax-8 expression. However, a Pax-8 independent bcl-2 expression is also evident.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma, Follicular / chemistry
  • Adenocarcinoma, Follicular / pathology
  • Adenoma / chemistry
  • Adenoma / pathology
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma / chemistry
  • Carcinoma / pathology
  • Carcinoma, Medullary / chemistry
  • Carcinoma, Medullary / pathology
  • Carcinoma, Papillary / chemistry
  • Carcinoma, Papillary / pathology
  • Cell Differentiation
  • DNA-Binding Proteins / analysis*
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Middle Aged
  • Neoplasm Proteins / analysis
  • Nuclear Proteins*
  • PAX8 Transcription Factor
  • Paired Box Transcription Factors
  • Proto-Oncogene Proteins c-bcl-2 / analysis*
  • Thyroid Diseases / metabolism*
  • Thyroid Diseases / pathology
  • Thyroid Neoplasms / chemistry
  • Thyroid Neoplasms / pathology
  • Trans-Activators / analysis*
  • Tumor Suppressor Protein p53 / analysis*

Substances

  • DNA-Binding Proteins
  • Neoplasm Proteins
  • Nuclear Proteins
  • PAX8 Transcription Factor
  • PAX8 protein, human
  • Paired Box Transcription Factors
  • Proto-Oncogene Proteins c-bcl-2
  • Trans-Activators
  • Tumor Suppressor Protein p53